Advertisement

Artificial cell-encapsulated enzymes and adsorbents in congenital metabolic disorders

  • T. M. S. Chang

Abstract

The present status of artificial cell-encapsulated enzymes and adsorbents and the feasibility of using them for removing or converting accumulated metabolites will be discussed. For the present discussion it is convenient to divide congenital metabolic disorders1,2 into two major groups: (1) those with extracellular or intracellular accumulation of metabolites, which might be helped by the removal of the metabolites from the extracellular fluid; and (2) those with intracellular accumulation of metabolites which cannot be removed by extracellular means.

Keywords

Activate Charcoal Inborn Error Fulminant Hepatic Failure Cellulose Nitrate Extracellular Compartment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Scriver, C. R. (1977). A biomedical view of enzyme replacement strategies in genetic disease. In Chang, T. M. S. (ed.) Biomedical Applications of Immobilized Enzymes and Proteins, Vol. I, pp. 121-146. (New York: Plenum Press)Google Scholar
  2. 2.
    Desnick, R. J., Bernlohr, R. W. and Krivit, W. (1973). Enzyme Therapy in Genetic Diseases, p. 236. (Baltimore: Williams & Wilkins)Google Scholar
  3. 3.
    Chang, T. M. S. (1964). Semipermeable microcapsules. Science, 146, 524PubMedCrossRefGoogle Scholar
  4. 4.
    Chang, T. M. S. (1972). Artificial Cells, p. 212. (Springfield: Thomas)Google Scholar
  5. 5.
    Chang, T. M. S. (1969). Removal of endogenous and exogenous toxins by a microencapsulated absorbent. Can. J. Physiol. Pharmacol., 47, 1043PubMedCrossRefGoogle Scholar
  6. 6.
    Chang, T. M. S. (1977). Criteria, evaluation, and perspectives of various microencapsulated charcoal hemoperfusion systems. J. Dial. Transpl., 6, 50Google Scholar
  7. 7.
    Chang, T. M. S., Coffey, J. F., Barre, P., Gonda, A., Dirks, J. H. Levy, M. and Lister, C. (1973). Microcapsule artificial kidney: Treatment of patients with acute drug intoxication. Can. Med. Assoc. J., 108, 429PubMedGoogle Scholar
  8. 8.
    Chang, T. M. S., Espinosa-Melendez, E., Francoeur, T. E. and Eade, N. (1980). Albumin-collodion activated charcoal hemoperfusion in the treatment of severe theophylline intoxication in a 3-year-old patient. Pediatrics, 65, 811PubMedGoogle Scholar
  9. 9.
    Chang, T. M. S. (1972). Haemoperfusions over microencapsulated adsorbent in a patient with hepatic coma. Lancet, 2, 1371PubMedCrossRefGoogle Scholar
  10. 10.
    Gazzard, B. G., Weston, M. H., Murray-Lyon, I. M., Flax, H., Record, C. O., Portman, B., Langley, P. G., Dunlop, E. H., Mellon, P. J., Ward, M. D. and William, S. R. (1974). Charcoal hemoperfusion in the treatment of fulminating hepatic failure. Lancet, 1, 1301PubMedCrossRefGoogle Scholar
  11. 11.
    Chang, T. M. S., Lister, C., Chirito, E., O’Keefe, P. and Resurreccion, E. (1978). Effects of hemoperfusion rate and time of initiation of AC AC charcoal hemoperfusion on the survival of fulminant hepatic failure rats. Trans. Am. Soc. Artif. Intern. Organs, 24, 243PubMedGoogle Scholar
  12. 12.
    Chang, T. M. S. (1977). Biomedical Applications of Immobilized Enzymes and Proteins. Vols. I and II, p. 415. (New York: Plenum Press)Google Scholar
  13. 13.
    Chang, T. M. S. (1971). The in vivo effects of semipermeable microcapsules containing L-asparaginase on 6C3HED lymphosarcoma. Nature (London), 229, 117PubMedCrossRefGoogle Scholar
  14. 14.
    Chang, T. M. S. and Poznansky, M. J. (1968). Semipermeable microcapsules containing catalase for enzyme replacement in acatalasemic mice. Nature (London), 218, 243PubMedCrossRefGoogle Scholar
  15. 15.
    Poznansky, M. J. and Chang, T. M. S. (1974). Comparison of the enzyme kinetics and immunological properties of catalase immobilized by microencapsulation and catalase in free solution for enzyme replacement. Biochim. Biophys. Acta, 334, 103Google Scholar
  16. 16.
    Gregoriadis, G., Leathwood, P. D. and Ryman, B. E. (1971). Enzyme entrapment in liposomes. FEBS Lett., 14, 95PubMedCrossRefGoogle Scholar
  17. 17.
    Gregoriadis, G. (1977). Liposomes as carriers of enzymes and proteins in medicine. In Chang, T. M. S. (ed.). Biomedical Applications of Immobilized Enzymes and Proteins, Vol. I, pp. 191-215. (New York: Plenum Press)Google Scholar
  18. 18.
    Ihler, G. and Glew, R. (1977). Enzyme-loaded erythrocytes. In Chang, T. M. S. (ed.) Biomedical Applications of Immobilized Enzymes and Proteins, Vol. I, pp. 219-226. (New York: Plenum Press)Google Scholar
  19. 19.
    Chang, T. M. S. (1976). Hemoperfusion alone and in series with ultrafiltration or dialysis for uremia, poisoning and liver failure. Kidney Int., 10, S305Google Scholar
  20. 20.
    Chang, T. M. S. (1978). Artificial Kidney, Artificial Liver, and Artificial Cells, p. 315. (New York: Plenum Press)Google Scholar
  21. 21.
    Sideman, S. and Chang, T. M. S. (1980). Hemoperfusion: Part I - Artificial Kidney and Liver Support and Detoxification, p. 473. (Washington: Hemisphere)Google Scholar
  22. 22.
    Nasielski, P. and Chang, T. M. S. (1978). Microencapsulated charcoal hemoperfusion for galactosemia. In Chang, T. M. S. (ed.) Artificial Kidney, Artificial Liver, and Artificial Cells, pp. 255-257. (New York: Plenum Press)Google Scholar
  23. 23.
    Kaziuka, E. N. and Chang, T. M. S. (1979). In-vitro assessment of the removal of phenols by ACAC hemoperfusion. Int. J. Artif. Organs, 2, 215PubMedGoogle Scholar
  24. 24.
    Chang, T. M. S. and Lister, C. (1980). Analysis of possible toxins in hepatic coma including the removal of mercaptan by albumin-collodion charcoal. Int. J. Artif Organs, 3, 108PubMedGoogle Scholar
  25. 25.
    Odaka, M., Tabata, Y., Kobayashi, H., Nomura, Y., Soma, H., Hirasawa, H. and Sato, H. (1978). Clinical experience of bead-shaped charcoal hemoperfusion in chronic renal failure and fulminant hepatic failure. In Chang, T. M. S. (ed.). Artificial Kidney, Artificial Liver, and Artificial Cells, pp. 79-88. (New York: Plenum Press)Google Scholar
  26. 26.
    Shu, C. D. and Chang, T. M. S. (1980). Tyrosinase immobilized within artificial cells for detoxification in liver failure: I. Preparation and in-vitro studies. Int. J. Artif. Organs, 3, 287PubMedGoogle Scholar
  27. 27.
    Shu, C. D. and Chang, T. M. S. (1981). Tyrosinase immobilized within artificial cells for detoxification in liver failure: II. In-vivo studies in fulminant hepatic failure rats. Int. J. Artif. Organs, 4, 82PubMedGoogle Scholar
  28. 28.
    Chang, T. M. S. and Malouf, C. (1978). Artificial cells microencapsulated multienzyme system for converting urea and ammonia to amino acid using a-ketoglutarate and glucose as substrate. Trans. Am. Soc. Artif Intern. Organs, 24, 18PubMedGoogle Scholar
  29. 29.
    Chang, T. M. S., Malouf, C. and Resurreccion, E. (1979). Artificial cells containing multienzyme systems for the sequential conversion of urea into ammonia, glutamate and alanine. Int. J. Artif Organs, 3, (suppl.), 284Google Scholar
  30. 30.
    Brusilow, S., Tinker, J. and Batshaw, M. L. (1980). Amino acid acylation. Science, 207, 659PubMedCrossRefGoogle Scholar
  31. 31.
    William, S. L. Y. (1980). Saccharide traffic signals in receptor-mediated endocytosis and transport of acid hydrolases. In Svennerholm, L., Mandel, P., Dreyfus, H. and Urban, P. (eds.) Structure and Function of the Gangliosides, pp. 433-441. (New York: Plenum Press)Google Scholar
  32. 32.
    Gregoriadis, G. (1979). Drug Carriers in Biology and Medicine, p. 363. (New York: Academic Press)Google Scholar
  33. 33.
    Belchetz, P. E., Braidman, I. P., Crawley, J. C. W. and Gregoriadis, G. (1977). Treatment of Gaucher’s disease with liposome-entrapped glucocerebroside: β-glucosidase. Lancet, 2, 116PubMedCrossRefGoogle Scholar
  34. 34.
    Desnick, R. J. (1980). Enzyme Therapy in Genetic Diseases. Vol. 2, p. 544. (New York: Liss)Google Scholar

Copyright information

© The Society for the Study of Inborn Errors of Metabolism 1982

Authors and Affiliations

  • T. M. S. Chang

There are no affiliations available

Personalised recommendations